FHC
NVCR icon

First Horizon Corporation’s NovoCure NVCR Stock Holding History

First Horizon Corporation’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1K Hold
6
– – ﹤0.01% 1027
2021
Q1 		$0 Hold
6
– – ﹤0.01% 1160
2020
Q4 		$1K Hold
6
– – ﹤0.01% 995
2020
Q3 		$0 Buy
+6
New +$480 ﹤0.01% 1129

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Horizon Corporation's NVCR Position: Q2 2021 in Review

First Horizon Corporation held its NovoCure (NVCR) position steady in Q2 2021 at 6 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

First Horizon Corporation first reported a position in NVCR in Q3 2020 and has held it in 4 quarters since. 361 funds tracked by Wall St. Rank hold NVCR as of Q2 2021.

  • First Horizon Corporation held 6 shares of NovoCure worth $1K as of Q2 2021.
  • First Horizon Corporation left its NovoCure share count unchanged in Q2 2021.
  • NovoCure made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #1027 holding.
  • First Horizon Corporation first reported a position in NovoCure in Q3 2020 and has held it in 4 quarters since.
  • 361 funds tracked by Wall St. Rank held NovoCure as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.